Jim Weaver has had two major surgeries in the past decade: one to remove cancerous tumors from his bladder and another to clear a blocked artery.
Sanofi sells rare disease drug Enjaymo to Recordati for $825M upfront
Sanofi is offloading its rare autoimmune disease medicine Enjaymo to an Italian pharmaceutical company for $825 million upfront. Recordati, based in Milan, Sign up to
October 5, 2024